华润医药：1H22业绩巩固了FY22E的正面
Resilient FY22／1H23 despite industry headwinds
Nayuki Holdings Limited (2150 HK) 期待 FY22E 的数字化
FY22收入8.84亿人民币，调后净利0.98亿派息率50%
FY22 net margins better than expected
FY22业绩不及预期；零售能力强化
Yalla(YALA)4Q22&FY22业绩会纪要–20230314
Outperforming FY22E, promising FY23E and not-far-fetching FY25E target
Hopson： weaker but much better than peers FY22
FY22E preview; Bumpy recovery in 2023
公众号
小程序
社群
公众号小程序社群